Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus Infection

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 3, 1997, Pages 401-414

  Denning, D W ^a,b,c   Radford, S A ^d   Oakley, K L ^b   Hall, L ^a   Johnson, E M ^d   Warnock, D W ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; EXPERIMENTAL INFECTION; INTRAGASTRIC DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PREDICTION;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; HUMANS; ITRACONAZOLE; MALE; MICE; MICROBIAL SENSITIVITY TESTS; NEUTROPENIA; SURVIVAL RATE;

EID: 0030824612     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.3.401     Document Type: Article

References (42)

1. Denning, D. W. (1994). Invasive aspergillosis in immunocompromised patients. Current Opinions in Infectious Diseases 7, 456-62.
2. Gallis, H. A., Drew, R. H. & Pickard, W. W. (1990). Amphotericin B: 30 years of clinical experience. Reviews of Infectious Diseases 12, 308-29.
3. Khoo, S. H., Bond, J. & Denning, D. W. (1994). Administering amphotericin B. A practical approach. Journal of Antimicrobial Chemotherapy 33, 203-13.
4. Denning, D. W. (1996). Therapeutic outcome of invasive aspergillosis. Clinical Infectious Diseases 23, 608-15.
5. Lister, J. (1996). Amphotericin B lipid complex (Abelcet) in the treatment of invasive mycoses: the North American experience. European Journal of Haematology 56, Suppl., 18-23.
6. Mills, W., Chopra, R., Linch, D. C. & Goldstone, A. H. (1994). Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. British Journal of Haematology 86, 754-60.
7. Ng, T. T. & Denning, D. W. (1995). Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data. Archives of Internal Medicine 155, 1093-8.
8. Oppenheim, B. A., Herbrecht, R. & Kusne, S. (1995). The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clinical Infectious Diseases 21, 1145-53.
9. Denning, D. W., Tucker, R. M., Hanson, L. H. & Stevens, D. A. (1989). Treatment of invasive aspergillosis with itraconazole. American Journal of Medicine 86, 791-800.
10. Denning, D. W., Lee, J. Y., Hostetler, J. S., Pappas, P., Kauffman, C. A., Dewsnup, D. H. et al. (1994). Multicenter trial of oral itraconazole therapy of invasive aspergillosis. American Journal of Medicine 97, 135-44.
11. Dupont, B. (1990). Itraconazole therapy in aspergillosis: study in 49 patients. Journal of the American Academy of Dermatology 23, 607-14.
12. De Buele, K., de Doncker, P., Cauwenbergh, G., Koster, M., Legendre, R., Blatchford, N. et al. (1988). The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses 31, 476-85.
13. Van't Wout, J. W., Novakova, I., Verhagen, C. A. H., Fibbe, W. E., de Pauw, B. E. & van der Meer, J. W. M. (1991). The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. Journal of Infection 22, 45-52.
14. Kreisel, W., Köchling, G., von Schilling, C., Azemar, M., Kurzwell, B., Dölken, G. et al. (1991). Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis. Mycoses 34, 385-94.
15. Caillot, D., Casasnovas, O., Bernard, A., Couaillier, J.-F., Durand, C., Cuisenier, B. et al. (1997). Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. Journal of Clinical Oncology 15, 139-47.
16. Yeldandi, V., Laghi, F., McCabe, M. A., Larson, R., O'Keefe, P., Husain, A. et al. (1995) Aspergillus and lung transplantation. Journal of Heart & Lung Transplantation 14, 883-90.
17. Sánchez, C., Mauri, E., Dalmau, D., Quintana, S., Aparicio, A. & Garau, J. (1995) Treatment of cerebral aspergillosis with itraconazole: do high doses improve the prognosis? Clinical Infectious Diseases 21, 1485-7.
18. Kac, G., Roux, P., Poirot, J. L., Meyohas, M. C., Cadranel, J., Chouaid, C. et al. (1995) Aspergillus et aspergilloses: étude rétrospective dans deux hôpitaux parisiens. Journal of Mycologie Médicale 5, 75-65.
19. Denning, D. W., Hanson, L. H., Perlman, A. M. & Stevens, D. A. (1992). In-vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagnostic Microbiology and Infectious Disease 15, 21-34.
20. Yamada, H., Kohno, S., Maesaki, S., Koga, H., Kaku, M., Hara, K. et al. (1993). Raoid and highly reproducible method for antifungal susceptibility testing of Aspergillus species. Journal of Clinical Microbiology 31, 1009-12.
21. Jahn, B., Martin, E., Stuben, A. & Bhakdi, S. (1995). Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. Journal of Clinical Microbiology 33, 661-7.
22. Gehrt, A., Peter J., Pizzo, P. A. & Walsh, T. J. (1995). Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. Journal of Clinical Microbiology 33, 1302-7.
23. Denning, D. W., Venkateswarlu, K., Oakley, K., Anderson, M. J., Manning, N. J., Stevens, D. A. et al. (1997). Itraconazole resistance in Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy 41, 1364-8.
24. National Committee for Clinical Laboratory Standards. (1995). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Tentative Standard, M27-T. NCCLS, Villanova, PA.
25. Velez, J. D., Allendoerfer, R., Luther, M., Rinaldi, M. G. & Graybill, J. R. (1993). Correlation of in-vitro azole susceptibility with in-vivo response in a murine model of cryptococcal meningitis. Journal of Infectious Diseases 168, 508-10.
26. Anaissie, E. J., Karyotakis, N. C., Hachem, R., Dignani, M. C., Rex, J. H. & Paetznick, V. (1994). Correlation between in-vitro and in-vivo activity of antifungal agents against Candida species. Journal of Infectious Diseases 170, 384-9.
27. Graybill, J. R., Najvar, L. K., Holmberg, J. D., Correa, A. & Luther, M. F. (1995). Fluconazole treatment of Candida albicans infection in mice: does in-vitro susceptibility predict in-vivo response? Antimicrobial Agents and Chemotherapy 39, 2197-200.
28. Rodriguez-Tudela, J. L., Martinez-Suarez, J. V., Dronda, F., Laguna, F., Chaves, F. & Valencia, E. (1995). Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. Journal of Antimicrobial Chemotherapy 35, 793-804.
29. Ghannoum, M. A., Rex, J. H. & Galgiani, J. N. (1996). Susceptibility testing of fungi: current status of correlation of in-vitro data with clinical outcome. Journal of Clinical Microbiology 34, 489-95.
30. Quereda, C., Polanco, A. M., Giner, C., Sánchez-Sousa, A., Pereira, E., Navas, E. et al. (1996). Correlation between in-vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients. European Journal of Clinical Microbiology and Infectious Diseases 15, 30-7.
31. Valentin, A., Le Guennec, R., Rodriguez, E., Reynes, J., Mallie, M. & Bastide, J.-M. (1996). Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in-vitro and in-vivo in a murine model. Antimicrobial Agents and Chemotherapy 40, 1342-45.
32. Espinel-Ingroff, A., Dawson, K., Pfaller, M., Anaissie, E., Breslin, B., Dixon, D. et al. (1995). Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrobial Agents and Chemotherapy 30, 314-19.
33. Denning, D. W., Stepan, D. E., Blume, K. G. & Stevens, D. A. (1992). Control of invasive pulmonary aspergillosis with oralitraconazole in a bone marrow transplant patient. Journal of Infection 24, 73-9.
34. Carlson, G. L., Birch, M., Mughal, M. M. & Denning, D. W. (1996). Aspergillus wound infection following laparostomy. Journal of Infection 33, 119-22.
35. Denning, D. W., Hall, L. Jackson, M. & Hollis, S. (1995). Efficacy of D0870 in 2 murine models of invasive aspergillosis compared with those of itraconazole and amphotericin B. Antimicrobial Agents and Chemotherapy 39, 1809-14.
36. De Waard, M. A. & van Nistelrooy, J. G. M. (1980). An energy-dependent efflux mechanism for fenarimol in a wild-type strain and fenarimol-resistant mutants of Aspergillus nidulans. Pesticidal Biochemistry and Physiology 13, 255-66.
37. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.-L., Monod, M. & Bille, J. (1995). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrobial Agents and Chemotherapy 39, 2378-66.
38. Espinel-Ingroff, A., Kish, C. W., Kerkering, T. M., Fromtling, R. A., Bartizal, K., Galgiani, J. N. et al. (1992). Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. Journal of Clinical Microbiology 30, 3138-45.
39. Rex, J. H., Pfaller, M. A., Rinaldi, M. G., Polak, A. & Galgiani, J. N. (1993). Antifungal susceptibility testing. Clinical Microbiology Reviews 6, 367-81.
40. Galgiani, J. N. & Stevens, D. A. (1976). Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size. Antimicrobial Agents and Chemotherapy 10, 721-8.
41. Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R. & Scully, C. (1995). Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Journal of Antimicrobial Chemotherapy 35, 103-14.
42. Jahn, B., Stuben, A. & Bhakdi, S. (1996). Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests. Journal of Clinical Microbiology 34, 2039-41.